Article Versions Notes

Ariyoshi T, Hagihara M, Tomono S, Eguchi S, Minemura A, Miura D, Oka K, Takahashi M, Yamagishi Y, Mikamo H. Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host. Biomedicines. 2021; 9(8):1065. https://doi.org/10.3390/biomedicines9081065

Ariyoshi, Tadashi, Mao Hagihara, Susumu Tomono, Shuhei Eguchi, Ayaka Minemura, Daiki Miura, Kentaro Oka, Motomichi Takahashi, Yuka Yamagishi, and Hiroshige Mikamo. 2021. "Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host" Biomedicines 9, no. 8: 1065. https://doi.org/10.3390/biomedicines9081065

Ariyoshi, T., Hagihara, M., Tomono, S., Eguchi, S., Minemura, A., Miura, D., Oka, K., Takahashi, M., Yamagishi, Y., & Mikamo, H. (2021). Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host. Biomedicines, 9(8), 1065. https://doi.org/10.3390/biomedicines9081065